CellaVision Management

Management Kriterienprüfungen 2/4

CellaVision's CEO ist Simon Ostergaard , ernannt in Mar 2021, hat eine Amtszeit von 3.25 Jahren. besitzt direkt 0.021% der Aktien des Unternehmens, im Wert von SEK1.27M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 3.3 Jahre bzw. 3.4 Jahre.

Wichtige Informationen

Simon Ostergaard

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	3.5yrs
Eigentum des Geschäftsführers	0.02%
Durchschnittliche Amtszeit des Managements	3.6yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	3.7yrs

Jüngste Management Updates

Recent updates

CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 24

CellaVision AB (publ)'s (STO:CEVI) Intrinsic Value Is Potentially 46% Above Its Share Price

Apr 09

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Mar 28

CellaVision's (STO:CEVI) Dividend Will Be SEK2.25

Mar 14

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Feb 29

After Leaping 28% CellaVision AB (publ) (STO:CEVI) Shares Are Not Flying Under The Radar

Feb 16

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Feb 12

Earnings Beat: CellaVision AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 10

CellaVision's (STO:CEVI) Returns On Capital Not Reflecting Well On The Business

Dec 13

Is Now An Opportune Moment To Examine CellaVision AB (publ) (STO:CEVI)?

Sep 14

Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)

Aug 22

CellaVision (STO:CEVI) Is Reinvesting At Lower Rates Of Return

Jun 17

CellaVision's (STO:CEVI) Upcoming Dividend Will Be Larger Than Last Year's

May 07

Estimating The Fair Value Of CellaVision AB (publ) (STO:CEVI)

Apr 19

CellaVision (STO:CEVI) Is Increasing Its Dividend To SEK2.25

Apr 05

CellaVision (STO:CEVI) Is Paying Out A Larger Dividend Than Last Year

Mar 04

CellaVision AB (publ) (STO:CEVI) Analysts Are More Bearish Than They Used To Be

Feb 11

Is CellaVision (STO:CEVI) A Risky Investment?

Jan 13

Is CellaVision AB (publ) (STO:CEVI) Potentially Undervalued?

Dec 13

CellaVision (STO:CEVI) Seems To Use Debt Rather Sparingly

Sep 23

CellaVision (STO:CEVI) May Have Issues Allocating Its Capital

Aug 16

Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)

Aug 02

We Ran A Stock Scan For Earnings Growth And CellaVision (STO:CEVI) Passed With Ease

Jun 27

What Is CellaVision AB (publ)'s (STO:CEVI) Share Price Doing?

May 31

CellaVision (STO:CEVI) Could Easily Take On More Debt

Apr 28

Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)

Apr 07

Geschäftsführer

Simon Ostergaard (53 yo)

3.5yrs

Amtszeit

Mr. Simon Ostergaard has been the Chief Executive Officer and President at CellaVision AB (publ) since March 21, 2021. He has broad experience is primarily in CellaVision's adjacent area of pathology and o...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Christer Fahraeus	Founder & Director	no data	SEK 285.00k	6.83% SEK 452.7m
Simon Ostergaard	CEO & President	3.5yrs	keine Daten	0.021% SEK 1.4m
Magnus Blixt	Chief Financial Officer	11.3yrs	keine Daten	0.017% SEK 1.1m
Adele Horn	Corporate Communications & Investor Relations Manager	no data	keine Daten	keine Daten
Peter Wilson	Vice President of Global Marketing	no data	keine Daten	0.013% SEK 834.1k
Urban Strindlov	Vice President of Global Sales	2.7yrs	keine Daten	keine Daten
Nina Wallander	Vice President of Human Resources	3.7yrs	keine Daten	keine Daten

3.6yrs

Durchschnittliche Betriebszugehörigkeit

57.5yo

Durchschnittliches Alter

Erfahrenes Management: CEVIDas Führungsteam des Unternehmens gilt als erfahren (3.3 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Christer Fahraeus	Founder & Director	30.7yrs	SEK 285.00k	6.83% SEK 452.7m
Mikael Worning	Independent Chairman of the Board	4.7yrs	SEK 800.00k	0.0099% SEK 655.8k
Stefan Wolf	Independent Director	6.3yrs	SEK 260.00k	keine Daten
Ann-Charlotte Jarleryd	Independent Director	2.3yrs	SEK 360.00k	keine Daten
Kent Strahlen	Independent Employee Representative Director	2.7yrs	keine Daten	0.0042% SEK 277.8k
Louise Armstrong-Denby	Independent Director	1.3yrs	SEK 130.00k	keine Daten

3.7yrs

Durchschnittliche Betriebszugehörigkeit

58.5yo

Durchschnittliches Alter

Erfahrener Vorstand: CEVIDie Vorstandsmitglieder gelten als erfahren (3.4 Jahre durchschnittliche Amtszeit).

CellaVision Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

Founder & Director recently sold kr27m worth of stock

Founder & Director recently bought kr63k worth of stock

CellaVision AB (publ) Announces the Appointment of Emil Hjalmarsson as Chairman of the Nomination Committee

Recent updates

Now 23% undervalued

Founder & Director recently sold kr27m worth of stock

CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Now 21% undervalued

Is CellaVision (STO:CEVI) A Risky Investment?

Does CellaVision (STO:CEVI) Deserve A Spot On Your Watchlist?

Investor sentiment improves as stock rises 15%

Upcoming dividend of kr2.25 per share

First quarter 2024 earnings released: EPS: kr1.26 (vs kr0.81 in 1Q 2023)

Full year 2023 earnings: EPS and revenues exceed analyst expectations

CellaVision (STO:CEVI) Is Due To Pay A Dividend Of SEK2.25

CellaVision AB (publ)'s (STO:CEVI) Intrinsic Value Is Potentially 46% Above Its Share Price

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

CellaVision's (STO:CEVI) Dividend Will Be SEK2.25

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Now 22% undervalued

Now 21% undervalued

After Leaping 28% CellaVision AB (publ) (STO:CEVI) Shares Are Not Flying Under The Radar

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Earnings Beat: CellaVision AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Dividend of kr2.25 announced

Price target increased by 21% to kr232

Consensus EPS estimates fall by 13%

Investor sentiment improves as stock rises 30%

Now 21% undervalued

CellaVision's (STO:CEVI) Returns On Capital Not Reflecting Well On The Business

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 18%

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

CellaVision AB (publ) to Report Nine Months, 2024 Results on Oct 24, 2024

CellaVision AB (publ) to Report Q3, 2023 Results on Oct 25, 2023

Price target decreased by 8.0% to kr203

Is Now An Opportune Moment To Examine CellaVision AB (publ) (STO:CEVI)?

Now 21% undervalued after recent price drop

Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)

Price target increased by 8.6% to kr220

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 17%

CellaVision AB (publ) to Report Q2, 2023 Results on Jul 20, 2023

Investor sentiment deteriorates as stock falls 17%

CellaVision (STO:CEVI) Is Reinvesting At Lower Rates Of Return

CellaVision's (STO:CEVI) Upcoming Dividend Will Be Larger Than Last Year's

Cellavision AB (Publ) Approves Dividend, Payable on May 12, 2023

Upcoming dividend of kr2.25 per share at 1.3% yield

Consensus EPS estimates increase by 13%

Consensus EPS estimates fall by 11%

Consensus EPS estimates fall by 11%

Estimating The Fair Value Of CellaVision AB (publ) (STO:CEVI)

Price target decreased by 11% to kr223

Full year 2022 earnings: EPS and revenues miss analyst expectations

CellaVision (STO:CEVI) Is Increasing Its Dividend To SEK2.25

Now 22% undervalued after recent price drop

CellaVision (STO:CEVI) Is Paying Out A Larger Dividend Than Last Year

Now 21% undervalued after recent price drop

Founder & Director recently bought kr63k worth of stock

CellaVision AB (publ) (STO:CEVI) Analysts Are More Bearish Than They Used To Be

Full year 2022 earnings released: EPS: kr4.96 (vs kr5.26 in FY 2021)

Cellavision AB (Publ) Proposes Dividend for 2022

Now 23% undervalued

Investor sentiment improves as stock rises 15%

Is CellaVision (STO:CEVI) A Risky Investment?

Now 21% undervalued after recent price drop

Investor sentiment improved over the past week

Is CellaVision AB (publ) (STO:CEVI) Potentially Undervalued?

Now 21% undervalued after recent price drop

CellaVision AB (publ) Announces the Appointment of Emil Hjalmarsson as Chairman of the Nomination Committee

Price target decreased to kr253

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: kr1.56 (vs kr1.30 in 2Q 2021)

Now 28% undervalued after recent price drop

Investor sentiment improved over the past week